Hamid Reza Mirzaei, PhD

About Hamid Reza Mirzaei, PhD

Hamid Reza Mirzaei, PhD, With an exceptional h-index of 44 and a recent h-index of 43 (since 2020), a distinguished researcher at Tehran University of Medical Sciences, specializes in the field of Cancer Immunology, Cancer Immunotherapy, Engineered Immunotherapeutics.

His recent articles reflect a diverse array of research interests and contributions to the field:

The inhibitory receptors PD1, Tim3, and A2aR are highly expressed during mesoCAR T cell manufacturing in advanced human epithelial ovarian cancer

MicroRNA-124 Enhances T Cells Functions by Manipulating the Lactic Acid Metabolism of Tumor Cells

CD8+ chimeric antigen receptor T cells manufactured in absence of CD4+ cells exhibit hypofunctional phenotype

Outsmarting trogocytosis to boost CAR NK/T cell therapy

Crosstalk between autophagy and metabolic regulation of (CAR) T cells: therapeutic implications

PGE2-EP2/EP4 Signaling Elicits mesoCAR T Cell Immunosuppression in Pancreatic Cancer

Role of Exosomes in the Treatment of Diseases

Exosomes

Hamid Reza Mirzaei, PhD Information

University

Position

Department of Immunology School of Medicine

Citations(all)

18067

Citations(since 2020)

12360

Cited By

14516

hIndex(all)

44

hIndex(since 2020)

43

i10Index(all)

74

i10Index(since 2020)

71

Email

University Profile Page

Google Scholar

Hamid Reza Mirzaei, PhD Skills & Research Interests

Cancer Immunology

Cancer Immunotherapy

Engineered Immunotherapeutics

Top articles of Hamid Reza Mirzaei, PhD

Title

Journal

Author(s)

Publication Date

The inhibitory receptors PD1, Tim3, and A2aR are highly expressed during mesoCAR T cell manufacturing in advanced human epithelial ovarian cancer

Cancer Cell International

Behnia Akbari

Tahereh Soltantoyeh

Zahra Shahosseini

Fariba Yarandi

Jamshid Hadjati

...

2023/5/27

MicroRNA-124 Enhances T Cells Functions by Manipulating the Lactic Acid Metabolism of Tumor Cells

Iranian Journal of Allergy, Asthma and Immunology

Mohammad Khakpoor-Koosheh

Hosein Rostamian

Elham Masoumi

Leila Jafarzadeh

Keyvan Fallah-Mehrjardi

...

2023/2/25

CD8+ chimeric antigen receptor T cells manufactured in absence of CD4+ cells exhibit hypofunctional phenotype

Journal for Immunotherapy of Cancer

Sang Yun Lee

Dong Hoon Lee

Wei Sun

Francisco Cervantes-Contreras

Ryan S Basom

...

2023

Outsmarting trogocytosis to boost CAR NK/T cell therapy

Faezeh Ramezani

Ahmad Reza Panahi Meymandi

Behnia Akbari

Omid Reza Tamtaji

Hamed Mirzaei

...

2023/11/16

Crosstalk between autophagy and metabolic regulation of (CAR) T cells: therapeutic implications

Ahmad Reza Panahi Meymandi

Behnia Akbari

Tahereh Soltantoyeh

Jamshid Hadjati

Daniel J Klionsky

...

2023/8/22

PGE2-EP2/EP4 Signaling Elicits mesoCAR T Cell Immunosuppression in Pancreatic Cancer

Frontiers in Immunology

Behnia Akbari

Tahereh Soltantoyeh

Zahra Shahosseini

Farhad Jadidi-Niaragh

Jamshid Hadjati

...

2023/6/30

Role of Exosomes in the Treatment of Diseases

Hamed Mirzaei

Neda Rahimian

Hamid Reza Mirzaei

Javid Sadri Nahand

Michael R Hamblin

2022

Exosomes

Hamed Mirzaei

Neda Rahimian

Hamid Reza Mirzaei

Javid Sadri Nahand

Michael R Hamblin

2022

The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019

The Lancet

Khanh Bao Tran

Justin J Lang

Kelly Compton

Rixing Xu

Alistair R Acheson

...

2022/8/20

MicroRNAs in cancer

Jianzhong Jeff Xi

2013

Adaptive immunity

The Neurology of AIDS

Jessica AL Hutter-Saunders

Larisa Y Poluektova

Subhash Dhawan

Howard E Gendelman

2011/11/29

Exosomes and MicroRNAs in biomedical science

Hamed Mirzaei

Neda Rahimian

Hamid Reza Mirzaei

Javid Sadri Nahand

Michael R Hamblin

2022/4/21

Exosomes and Non-Cancer Diseases

Hamed Mirzaei

Neda Rahimian

Hamid Reza Mirzaei

Javid Sadri Nahand

Michael R Hamblin

2022

Role of the bone marrow microenvironment in drug resistance of hematological malignances

Alireza Hosseini

Michael R Hamblin

Hamed Mirzaei

Hamid R Mirzaei

2022/4/1

MicroRNAs in non-malignant diseases

Hamed Mirzaei

Neda Rahimian

Hamid Reza Mirzaei

Javid Sadri Nahand

Michael R Hamblin

2022

Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis …

JAMA oncology

Jonathan M Kocarnik

Kelly Compton

Frances E Dean

Weijia Fu

Brian L Gaw

...

2022/3/1

Soluble and immobilized anti-CD3/28 distinctively expand and differentiate primary human T cells: an implication for adoptive T cell therapy

Iranian Journal of Allergy, Asthma and Immunology

Tahereh Soltantoye

Behnia Akbari

Hamid Reza Mirzaei

Jamshid Hadjati

2022/12/24

Exosomes and Cancer

Jeroen Vrij

Sybren Maas

Joost Hegmans

Martine Lamfers

Clemens Dirven

...

2011/12/1

Restricting tumor lactic acid metabolism using dichloroacetate improves T cell functions

BMC cancer

Hosein Rostamian

Mohammad Khakpoor-Koosheh

Leila Jafarzadeh

Elham Masoumi

Keyvan Fallah-Mehrjardi

...

2022/1/6

Metabolic and epigenetic orchestration of (CAR) T cell fate and function

Behnia Akbari

Zahra Hosseini

Pardis Shahabinejad

Saba Ghassemi

Hamid Reza Mirzaei

...

2022/12/1

See List of Professors in Hamid Reza Mirzaei, PhD University(Tehran University of Medical Sciences)

Co-Authors

academic-engine